His primary areas of study are Internal medicine, Endocrinology, Methadone, Opioid and Addiction. His Internal medicine research incorporates elements of Gastroenterology and Craving. Mary Jeanne Kreek has included themes like Receptor, Opioid antagonist and κ-opioid receptor in his Endocrinology study.
Buprenorphine is closely connected to Heroin in his research, which is encompassed under the umbrella topic of Methadone. His work in Opioid tackles topics such as Pharmacology which are related to areas like Agonist, Dynorphin and μ-opioid receptor. His Addiction research includes themes of Drug, Substance abuse, Endogenous opioid and Opiate.
His scientific interests lie mostly in Internal medicine, Endocrinology, Pharmacology, Methadone and Addiction. Internal medicine is represented through his Adrenocorticotropic hormone, Dynorphin, Naltrexone, Prolactin and Endogenous opioid research. Mary Jeanne Kreek frequently studies issues relating to Receptor and Endocrinology.
His research investigates the connection between Pharmacology and topics such as Opioid that intersect with issues in Morphine. His work deals with themes such as Buprenorphine and Narcotic, which intersect with Methadone. Mary Jeanne Kreek focuses mostly in the field of Addiction, narrowing it down to topics relating to Heroin and, in certain cases, Substance abuse.
His primary areas of investigation include Internal medicine, Endocrinology, Pharmacology, Opioid and Addiction. His Internal medicine research incorporates themes from Alcohol and Genotype. His Pharmacology study integrates concerns from other disciplines, such as Agonist, μ-opioid receptor, Antagonist and κ-opioid receptor.
His Opioid research also works with subjects such as
His main research concerns Pharmacology, Opioid, Addiction, Internal medicine and Heroin. His studies in Pharmacology integrate themes in fields like Striatum, Agonist, μ-opioid receptor, κ-opioid receptor and Oxycodone. The study incorporates disciplines such as SNP, Single-nucleotide polymorphism, Genetics, Case-control study and Allele frequency in addition to Addiction.
His Internal medicine research includes elements of Endocrinology and Polyunsaturated fatty acid, Fatty acid. His study in Endocrinology is interdisciplinary in nature, drawing from both Alcohol and Opioid receptor. His work in Heroin covers topics such as Methadone maintenance which are related to areas like Nod.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity : possible implications for opiate addiction
Cherie Bond;K. Steven LaForge;Mingting Tian;Dorothy Melia.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Genetic Influences on Impulsivity, Risk Taking, Stress Responsivity and Vulnerability to Drug Abuse and Addiction
Mary Jeanne Kreek;David A Nielsen;Eduardo R Butelman;K Steven LaForge.
Nature Neuroscience (2005)
Stress, Dysregulation of Drug Reward Pathways, and the Transition to Drug Dependence
George Koob;Mary Jeanne Kreek.
American Journal of Psychiatry (2007)
Drug dependence: stress and dysregulation of brain reward pathways.
Mary Jeanne Kreek;George F. Koob.
Drug and Alcohol Dependence (1998)
Stress-Induced Cocaine Craving and Hypothalamic-Pituitary-Adrenal Responses Are Predictive of Cocaine Relapse Outcomes
Rajita Sinha;Miguel Garcia;Prashni Paliwal;Mary Jeanne Kreek.
Archives of General Psychiatry (2006)
HIV-1 Infection Among Intravenous Drug Users in Manhattan, New York City, From 1977 Through 1987
Don C. Des Jarlais;Samuel R. Friedman;David M. Novick;Jo L. Sotheran.
JAMA (1989)
Effective medical treatment of opiate addiction
L. L. Judd;M. G. Marston;C. Attkisson;W. Berrettini.
JAMA (1998)
Pharmacotherapy of addictions
Mary Jeanne Kreek;K. Steven LaForge;Eduardo Butelman.
Nature Reviews Drug Discovery (2002)
Naltrexone decreases craving and alcohol self- administration in alcohol-dependent subjects and activates the hypothalamo--pituitary--adrenocortical axis.
Stephanie S O'Malley;Suchitra Krishnan-Sarin;Conor Farren;Rajita Sinha.
Psychopharmacology (2002)
1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.
Johan Kakko;Kerstin Dybrandt Svanborg;Mary Jeanne Kreek;Markus Heilig.
The Lancet (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Rockefeller University
Cornell University
Baylor College of Medicine
Rockefeller University
Rockefeller University
Yale University
Johns Hopkins University School of Medicine
Columbia University Medical Center
New York University
University of Amsterdam
University of Auckland
Technical University of Kaiserslautern
Harvard University
Johannes Kepler University of Linz
University of Helsinki
Oslo University Hospital
Genentech
University of Georgia
GEOMAR Helmholtz Centre for Ocean Research Kiel
University of Padua
National University of Córdoba
Ames Research Center
University of Cambridge
University of Wisconsin–Madison
University of California, Davis
University of Pennsylvania